GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Excelsior Medical Co 4104.TW · TWD

Health Care · Taiwan Stock Exchange · 🇹🇼 Taiwan

Compare

72.00

+0.28%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 8.79bn

FY2016FY2025

Net income

TWD 805.9m

FY2016FY2025

Free cash flow

−TWD 1.27bn

FY2016FY2025

Shareholders' equity

TWD 9.19bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 8.79bnTWD 8.54bnTWD 8.23bnTWD 7.19bnTWD 6.57bnTWD 6.68bnTWD 6.46bnTWD 6.35bnTWD 6.10bnTWD 6.21bn
Gross profitTWD 1.87bnTWD 1.78bnTWD 1.67bnTWD 1.51bnTWD 1.37bnTWD 1.31bnTWD 1.24bnTWD 1.20bnTWD 1.21bnTWD 1.20bn
Operating incomeTWD 739.8mTWD 749.7mTWD 702.9mTWD 869.9mTWD 769.2mTWD 843.1mTWD 774.7mTWD 472.3mTWD 478.4mTWD 381.4m
Net incomeTWD 805.9mTWD 771.3mTWD 746.6mTWD 667.5mTWD 607.1mTWD 571.7mTWD 514.8mTWD 451.6mTWD 399.0mTWD 389.6m
Diluted earnings per share3.904.494.544.063.903.703.593.152.782.73

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 18.98bnTWD 20.37bnTWD 18.08bnTWD 16.48bnTWD 15.11bnTWD 14.00bnTWD 13.76bnTWD 13.98bnTWD 14.95bnTWD 16.83bn
Cash and short-term investmentsTWD 3.46bnTWD 4.95bnTWD 3.41bnTWD 3.23bnTWD 3.77bnTWD 3.55bnTWD 3.41bnTWD 3.42bnTWD 3.53bnTWD 4.34bn
Total liabilitiesTWD 7.25bnTWD 9.01bnTWD 7.17bnTWD 6.19bnTWD 5.36bnTWD 4.42bnTWD 5.13bnTWD 5.64bnTWD 6.93bnTWD 8.52bn
DebtTWD 1.84bnTWD 1.42bnTWD 1.44bnTWD 808.0mTWD 762.0mTWD 712.6mTWD 1.46bnTWD 1.11bnTWD 1.47bnTWD 1.23bn
Shareholders' equityTWD 9.19bnTWD 8.97bnTWD 8.61bnTWD 8.20bnTWD 7.74bnTWD 7.59bnTWD 6.95bnTWD 6.81bnTWD 6.42bnTWD 6.51bn
Shares outstanding207m172m164m165m156m154m144m143m143m143m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−TWD 1.19bnTWD 2.47bnTWD 107.1mTWD 637.1mTWD 945.0mTWD 869.4mTWD 1.19bnTWD 192.4m−TWD 487.4mTWD 449.7m
Capital spending−TWD 77.8m−TWD 120.7m−TWD 126.4m−TWD 172.5m−TWD 168.8m−TWD 35.0m−TWD 52.0m−TWD 36.2m−TWD 36.9m−TWD 31.1m
Free cash flow−TWD 1.27bnTWD 2.35bn−TWD 19.3mTWD 464.6mTWD 776.3mTWD 834.4mTWD 1.14bnTWD 156.2m−TWD 524.3mTWD 418.6m
Dividends paid−TWD 620.9m−TWD 591.3m−TWD 541.0m−TWD 494.0m−TWD 494.0m−TWD 465.8m−TWD 384.4m−TWD 357.9m−TWD 319.1m−TWD 304.5m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 2.39bnTWD 2.34bnTWD 2.28bnTWD 2.19bnTWD 2.17bnTWD 2.15bnTWD 2.28bnTWD 2.06bn
Gross profitTWD 517.5mTWD 496.5mTWD 492.4mTWD 457.8mTWD 467.5mTWD 455.8mTWD 509.8mTWD 439.6m
Operating incomeTWD 196.3mTWD 180.4mTWD 167.4mTWD 183.0mTWD 198.3mTWD 181.2mTWD 226.2mTWD 188.1m
Net incomeTWD 345.6mTWD 205.2mTWD 193.9mTWD 186.9mTWD 229.8mTWD 195.2mTWD 192.2mTWD 173.6m
Diluted earnings per share1.650.980.940.901.110.941.121.01
Cash from operations—TWD 217.0mTWD 235.0m−TWD 254.0mTWD 99.0m−TWD 1.45bn−TWD 1.80bnTWD 3.87bn
Capital spending—−TWD 33.0m−TWD 10.0m−TWD 24.0m−TWD 16.0m−TWD 31.0m−TWD 27.0m−TWD 47.0m
Free cash flow—TWD 184.0mTWD 225.0m−TWD 278.0mTWD 83.0m−TWD 1.48bn−TWD 1.83bnTWD 3.82bn
Total assets—TWD 19.46bnTWD 18.98bnTWD 18.80bnTWD 18.43bnTWD 18.76bnTWD 20.37bnTWD 21.94bn
Cash and short-term investments—TWD 3.74bnTWD 3.46bnTWD 3.12bnTWD 2.93bnTWD 3.40bnTWD 4.95bnTWD 6.85bn
Debt—TWD 875.9mTWD 1.98bnTWD 1.62bnTWD 1.31bnTWD 998.5mTWD 1.05bnTWD 1.21bn
Shareholders' equity—TWD 9.63bnTWD 9.19bnTWD 8.87bnTWD 8.49bnTWD 8.57bnTWD 8.97bnTWD 8.78bn

Financial ratios

Data as of 1 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin21.3%20.9%20.3%21.1%20.9%19.6%
Operating margin8.4%8.8%8.5%12.1%11.7%12.6%
Net margin9.2%9.0%9.1%9.3%9.2%8.6%
Return on equity8.8%8.6%8.7%8.1%7.8%7.5%
Return on assets4.2%3.8%4.1%4.0%4.0%4.1%
Free cash flow yield-7.4%20.7%2.0%6.8%9.9%8.1%
Revenue growth2.9%3.7%14.6%9.3%-1.5%3.4%
Earnings growth4.5%3.3%11.9%9.9%6.2%11.1%
Current ratio1.67x1.47x1.60x1.66x1.88x2.11x
Debt to equity0.20x0.12x0.14x0.08x0.07x0.06x
Equity ratio48.4%44.0%47.6%49.8%51.2%54.2%
Interest coverage21.19x27.65x40.87x83.25x87.80x78.29x
Buybacks as a share of market value-20.2%-4.6%0.1%-5.8%-0.7%-7.6%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue6.9%5.7%3.5%
Operating income-5.3%-2.6%7.8%
Net income6.5%7.1%7.8%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin21.1%20.9%20.7%20.2%
Operating margin8.6%9.4%10.2%9.2%
Net margin9.1%9.1%9.1%8.2%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings20.919.218.515.112.713.113.012.613.914.3
Price to sales1.91.71.71.41.21.11.00.90.90.9

Dividends and splits

Per share, in the currency the company pays

Paid for 25 years. Last went ex-dividend on 23 Apr 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year4.303.5593.393.1012.8322.8322.672.398
  • 1050-for-1000 split · 9 Sept 2025
  • 21-for-20 split · 26 Aug 2024
  • 21-for-20 split · 28 Aug 2023
  • 21-for-20 split · 30 Aug 2022
  • 11-for-10 split · 19 Sept 2012
  • 100-to-79.9624 reverse split · 11 Dec 2007

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.